Kirstein, MM & Vogel, A. Epidemiology and risk factors of cholangiocarcinoma. Visc. Med. 32395–400 (2016).
Welzel, TM et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based case–control study. Clin. Gastroenterol. Hepatol. 51221–1228 (2007).
Shaib, YH, El-Serag, HB, Davila, JA, Morgan, R. & McGlynn, KA Risk factors of intrahepatic cholangiocarcinoma in the United States: A case–control study. Gastroenterology 128620–626 (2005).
Tao, LY et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A case-control study in China. Liver Int. 30215–221 (2010).
Shaib, YH et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A hospital-based case-control study. Am. J. Gastroenterol. 1021016–1021 (2007).
Clements, O., Eliahoo, J., Kim, JU, Taylor-Robinson, SD & Khan, SA Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J. Hepatol. 7295–103 (2020).
Chinchilla-Lopez, P. et al. Prevalence, risk factors, and survival of patients with intrahepatic cholangiocarcinoma. Ann. Hepatol. 16565–568 (2017).
Barner-Rasmussen, N., Pukkala, E., Hadkhale, K. & Farkkila, M. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. United Eur. Gastroenterol. J. 91128–1135 (2021).
Thinkhamrop, K. et al. Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand. Sci. Rep. 1016855 (2020).
Chamadol, N. et al. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. J. Hepat. Pancreat. Sci. 21316–322 (2014).
Apisarnthanarak, P., Pansri, C., Maungsomboon, K. & Thamtorawat, S. The CT appearances for differentiating peripheral, mass-forming cholangiocarcinoma and liver metastases from colorectal adenocarcinoma. J. Med. Assoc. Thai. 97415–422 (2014).
Banales, JM et al. Expert consensus document: Cholangiocarcinoma—current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13261–280 (2016).
Florio, AA et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 1262666–2678 (2020).
Chaiteerakij, R. et al. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study. World J. Gastroenterol. 237160–7167 (2017).
Sripa, B. & Pairojkul, C. Cholangiocarcinoma: Lessons from Thailand. Curr. Opin. Gastroenterol. 24349–356 (2008).
Khuntikeo, N. et al. Cohort profile: Cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 15459 (2015).
Khuntikeo, N. et al. A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. HPB (Oxford) 22874–883 (2020).
Khan, SA et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: An update. Gut 611657–1669 (2012).
Choi, BI et al. Hilar cholangiocarcinoma: Comparative study with sonography and CT. Radiology 172689–692 (1989).
Sungkasubun, P. et al. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: A population-based prospective study of 4225 subjects in an endemic area. BMC Cancer 16346 (2016).
Thinkhamrop, K. et al. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. PLoS Negl. Trop. Dec. 15e0009741 (2021).
Kamsa-ard, S. et al. Risk factors for cholangiocarcinoma in Thailand: A systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 19605–614 (2018).
Lee, BS, Cha, BH, Park, EC & Roh, J. Risk factors for perihilar cholangiocarcinoma: A hospital-based case–control study. Liver Int. 351048–1053 (2015).
Suwannatrai, AT et al. Bayesian spatial analysis of cholangiocarcinoma in Northeast Thailand. Sci. Rep. 914263 (2019).
Chun, YS, Pawlik, TM & Vauthey, JN 8th edition of the AJCC cancer staging manual: Pancreas and hepatobiliary cancers. Ann. Surg. Oncol. 25845–847 (2018).
Edge, SB & Compton, CC The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 171471–1474 (2010).
Baidoun, F., Sarmini, MT, Merjaneh, Z. & Moustafa, MA Controversial risk factors for cholangiocarcinoma. Eur. J. Gastroenterol. Hepatol. 34338–344 (2022).
Lim, JH Liver flukes: The neglected malady. Korean J. Radiol. 12269–279 (2011).
Fariduddin, MM, Syed, W., Birjees, A. & Naqvi, MR Liver infarct masquerading as intrahepatic cholangiocarcinoma. Proc. (Bayl. Univ. Med. Cent.) 34693–695 (2021).
Chamadol, N. et al. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: A cross-sectional study of cholangiocarcinoma screening in Northeast Thailand. BMJ Open 9e023217 (2019).